Taihua Plc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taihua Plc with three other
pharmaceutical manufacturers in Asia:
sales of 567.00 million Japanese Yen [US$5.09 million]
of which 89%
was iPS cell business),
Gujarat Themis Biosyn Limited
(314.40 million Indian Rupees [US$4.85 million]
Gennex Laboratories Limited
based in India
(318.97 million Indian Rupees [US$4.92 million]
Taihua Plc reported sales of 34.23 million Chinese Renmimbi (US$4.97 million)
December of 2015.
decrease of 32.8%
versus 2014, when the company's sales were 50.95 million Chinese Renmimbi.